Literature DB >> 25981843

Predictors of 30-day readmission and impact of same-day discharge in laparoscopic hysterectomy.

Ashley J Jennings1, Ryan J Spencer1, Erin Medlin1, Laurel W Rice1, Shitanshu Uppal2.   

Abstract

OBJECTIVE: The objective of the study was to identify the predischarge predictors of 30-day readmission and the impact of same-day discharge after laparoscopic hysterectomy. STUDY
DESIGN: Patients undergoing only laparoscopic hysterectomy with or without bilateral salpingo-oophorectomy participated in the study.
RESULTS: The 30-day readmission rate was 3.1% (277 of 8890). Factors predictive of higher rates of readmission were diabetes (4.4% vs 3.0%; P = .03), chronic obstructive pulmonary disease (8.5% vs 3.1%; P = .02), disseminated cancer (20% vs 3.1%; P < .001), chronic steroid use (7.1% vs 3.1%; P = .03), daily alcohol use of more than 2 drinks (12.5% vs 2.5%; P = .04), and bleeding disorder (10.8% vs 3%; P = .001). Operative factors included surgical time of 2 hours or greater (3.5% vs 2.7%; P = .014). After surgery, patients had a higher rate of readmission when they experienced any 1 or more complications prior to discharge, (6.9% vs 3.1%; P = .01) as well as any complication after discharge (3.6% vs 1.6%; P = .01). Infections (35.7%) and surgical complications (24.2%) were the most common reasons of readmissions. Of these patients, 20.9% were discharged the same day (n = 1855) and had a similar rate of readmission (2.6% vs 3.2%; P = n.s.). Laparoscopic hysterectomy readmission score (LHRS) can be calculated by assigning 1 point to diabetes, chronic obstructive pulmonary disease, disseminated cancer, chronic steroid use, bleeding disorder, length of surgery of 2 hours or longer, and 2 points to any postoperative complication prior to discharge. Readmission rates for the LHRS score were score 1 (2.4%), score 2 (3.3%), score 3 (5.8%), or score 4 (9.5%).
CONCLUSION: The overall readmission rate after laparoscopic hysterectomy is low. Patients discharged the same day have similar rates of readmission. Higher LHRS is indicative of higher rates of readmission and may identify a population not suitable for same-day discharge and in need of higher vigilance to prevent readmissions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  laparoscopic hysterectomy; readmission; same-day discharge; surgical complications

Mesh:

Substances:

Year:  2015        PMID: 25981843     DOI: 10.1016/j.ajog.2015.05.014

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women.

Authors:  Daniel M Morgan; Neil S Kamdar; Carolyn W Swenson; Emily K Kobernik; Anne G Sammarco; Brahmajee Nallamothu
Journal:  Am J Obstet Gynecol       Date:  2017-12-26       Impact factor: 8.661

2.  Feasibility of remote digital monitoring using wireless Bluetooth monitors, the Smart Angel™ app and an original web platform for patients following outpatient surgery: a prospective observational pilot study.

Authors:  Thierry Chevallier; Gautier Buzancais; Bob-Valéry Occean; Pierre Rataboul; Christophe Boisson; Natacha Simon; Ariane Lannelongue; Noémie Chaniaud; Yann Gricourt; Jean-Yves Lefrant; Philippe Cuvillon
Journal:  BMC Anesthesiol       Date:  2020-10-08       Impact factor: 2.217

3.  Short stay laparoscopic hysterectomy: An evaluation of feasibility and patient satisfaction.

Authors:  L Antoun; P Smith; Y Afifi; K Cullis; T J Clark
Journal:  Facts Views Vis Obgyn       Date:  2021-12

4.  Risk factors for unplanned admission following surgical repair of apical prolapse.

Authors:  Henry H Chill; Nani P Moss; Cecilia Chang; Joel Winer; Roger P Goldberg
Journal:  Int Urogynecol J       Date:  2022-09-19       Impact factor: 1.932

5.  Impact of Chronic Obstructive Pulmonary Disease on Laparoscopic Hysterectomy Outcome.

Authors:  Jensen N Galvis; Maria V Vargas; Hannah N Robinson; Paul Tyan; Alex Gu; Chapman Wei; Nikhila Janakiram; Gaby Moawad
Journal:  JSLS       Date:  2019 Jan-Mar       Impact factor: 2.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.